会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 5. 发明申请
    • RECOMBINANT HEPATITIS C VIRUS RNA REPLICASE
    • 重组HEPATITIS C病毒RNA替代物
    • WO1997012033A1
    • 1997-04-03
    • PCT/US1996015571
    • 1996-09-27
    • EMORY UNIVERSITY
    • EMORY UNIVERSITYHAGEDORN, Curt, H.AL, Reinoldus, H.
    • C12N09/12
    • C12N9/127
    • A recombinant RNA-dependent RNA polymerase of hepatitis C virus (r-HCV-RDRP) coding DNA was cloned and expressed yielding active enzyme in vitro. The r-HCV-RDRP can include up to 20 added amino acids and up to nine deleted or substituted amino acids at the NH2-terminus of the encoded amino acid sequence. The invention provides method to solubilize r-HCV-RDRP from a host cell lysate and purified r-HCV-RDRP. Methods for screening for inhibitors of r-HCV-RDRP in vitro, for making stably transfected mammalian cells expressing r-HCV-RDRP and for in vivo testing of r-HCV-RDRP inhibitors in vivo are disclosed. The invention provides antibodies to r-HCV-RDRP and methods for detecting antibodies to HCV-RDRP in serum of human patients.
    • 克隆并表达丙型肝炎病毒(r-HCV-RDRP)编码DNA的重组RNA依赖性RNA聚合酶,并在体外产生活性酶。 r-HCV-RDRP可以在编码的氨基酸序列的NH 2 - 末端包含多达20个添加的氨基酸和至多9个缺失或取代的氨基酸。 本发明提供从宿主细胞裂解物和纯化的r-HCV-RDRP中溶解r-HCV-RDRP的方法。 公开了用于在体内筛选r-HCV-RDRP抑制剂的方法,用于制备表达r-HCV-RDRP的稳定转染的哺乳动物细胞和体内r-HCV-RDRP抑制剂的体内测试。 本发明提供了对r-HCV-RDRP的抗体以及用于检测人类患者血清中HCV-RDRP抗体的方法。
    • 10. 发明申请
    • HUMAN TELOMERASE
    • 人类TELOMERASE
    • WO1998001542A1
    • 1998-01-15
    • PCT/US1997012296
    • 1997-07-08
    • THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    • THE REGENTS OF THE UNIVERSITY OF CALIFORNIACOLLINS, Kathleen
    • C12N09/12
    • C12N9/1241C07K14/70503C12P19/34
    • The invention provides methods and compositions relating to a human telomerase and related nucleic acids, including four distinct human telomerase subunit proteins called p140, p105, p48 and p43 having human telomerase-specific activity. The proteins may be produced recombinantly from transformed host cells from the disclosed telomerase encoding nucleic acids or purified from human cells. Also included are human telomerase RNA components, as well as specific, functional derivatives thereof. The invention provides isolated telomerase hybridization probes and primers capable of specifically hybridizing with the disclosed telomerase gene, telomerase-specific binding agents such as specific antibodies, and methods of making and using the subject compositions in diagnosis, therapy and in the biopharmaceutical industry.
    • 本发明提供了与人端粒酶和相关核酸相关的方法和组合物,包括具有人端粒酶特异性活性的称为p140,p105,p48和p43的四种不同的人端粒酶亚基蛋白。 可以从所公开的编码端粒酶的核酸转化的宿主细胞重组产生蛋白质,或从人细胞纯化。 还包括人端粒酶RNA组分以及其具体的功能性衍生物。 本发明提供了能够与所公开的端粒酶基因,端粒酶特异性结合剂如特异性抗体特异性杂交的分离的端粒酶杂交探针和引物,以及在诊断,治疗和生物制药工业中制备和使用该主题组合物的方法。